Literature DB >> 9112118

LNCaP-OM, a new androgen-resistant prostate cancer subline.

M Platica, R S Verma, M J Macera, O Platica.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9112118     DOI： 10.1007/s11626-997-0131-1

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN： 1071-2690            Impact factor:   2.416


× No keyword cloud information.
  11 in total

1.  Isolation of a human prostate carcinoma cell line (DU 145).

Authors:  K R Stone; D D Mickey; H Wunderli; G H Mickey; D F Paulson
Journal:  Int J Cancer       Date:  1978-03-15       Impact factor: 7.396

2.  Cytogenetic characterization of several androgen responsive and unresponsive sublines of the human prostatic carcinoma cell line LNCaP.

Authors:  J J König; E Kamst; A Hagemeijer; J C Romijn; J Horoszewicz; F H Schröder
Journal:  Urol Res       Date:  1989

3.  Androgen receptor gene expression in human prostate carcinoma cell lines.

Authors:  W D Tilley; C M Wilson; M Marcelli; M J McPhaul
Journal:  Cancer Res       Date:  1990-09-01       Impact factor: 12.701

4.  Phenotypic and cytogenetic characterization of a cell line derived from primary prostatic carcinoma.

Authors:  A R Brothman; L J Lesho; K D Somers; G L Wright; D J Merchant
Journal:  Int J Cancer       Date:  1989-11-15       Impact factor: 7.396

5.  Prostate-specific antigen messenger RNA is expressed in non-prostate cells: implications for detection of micrometastases.

Authors:  M R Smith; S Biggar; M Hussain
Journal:  Cancer Res       Date:  1995-06-15       Impact factor: 12.701

6.  Detection of micrometastatic prostate cancer cells in lymph nodes by reverse transcriptase-polymerase chain reaction.

Authors:  T Deguchi; T Doi; H Ehara; S Ito; Y Takahashi; Y Nishino; S Fujihiro; T Kawamura; H Komeda; M Horie
Journal:  Cancer Res       Date:  1993-11-15       Impact factor: 12.701

Review 7.  The human prostatic cancer cell line LNCaP and its derived sublines: an in vitro model for the study of androgen sensitivity.

Authors:  G J van Steenbrugge; C J van Uffelen; J Bolt; F H Schröder
Journal:  J Steroid Biochem Mol Biol       Date:  1991       Impact factor: 4.292

8.  Establishment and characterization of a human prostatic carcinoma cell line (PC-3).

Authors:  M E Kaighn; K S Narayan; Y Ohnuki; J F Lechner; L W Jones
Journal:  Invest Urol       Date:  1979-07

9.  Establishment and characterization of a new human prostatic carcinoma cell line (DuPro-1).

Authors:  J R Gingrich; J A Tucker; P J Walther; J W Day; S H Poulton; K S Webb
Journal:  J Urol       Date:  1991-09       Impact factor: 7.450

10.  LNCaP model of human prostatic carcinoma.

Authors:  J S Horoszewicz; S S Leong; E Kawinski; J P Karr; H Rosenthal; T M Chu; E A Mirand; G P Murphy
Journal:  Cancer Res       Date:  1983-04       Impact factor: 12.701
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.